Finance

Beta
Lists
DPHARMA:KLSE
Duopharma Biotech Bhd
MYR 1.22
-0.81%
(-0.0100) 1D
Jun 11, 11:58:18 AM GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for DPHARMA...
Open
MYR 1.23
High
MYR 1.25
Low
MYR 1.22
Mkt. cap
1.17B
Avg. vol.
686.70K
Volume
62.20K
Dividend
3.73%
Quarterly dividend
MYR 0.01
Ex-dividend date
Mar 12, 2026
P/E ratio
12.68
52-wk high
MYR 1.57
52-wk low
MYR 1.20
EPS
MYR 0.10
Shares outstanding
961.94M
No. of employees
2K
Open
MYR 1.23
High
MYR 1.25
Low
MYR 1.22
Mkt. cap
1.17B
Avg. vol.
686.70K
Volume
62.20K
Dividend
3.73%
Quarterly dividend
MYR 0.01
Ex-dividend date
Mar 12, 2026
P/E ratio
12.68
52-wk high
MYR 1.57
52-wk low
MYR 1.20
EPS
MYR 0.10
Shares outstanding
961.94M
No. of employees
2K
News stories
From sources across the web
About Duopharma Biotech Bhd
CEO-
Employees2K
Founded1978
Headquarters-
SectorPharmaceutical industry
Websiteduopharmabiotech.com
Previous reportsAll values in MYR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in MYR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
221.78M
222.49M
224.69M
247.88M
Cost of goods sold
138.73M
131.74M
128.63M
150.58M
Cost of revenue
138.73M
131.74M
128.63M
150.58M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
51.42M
56.11M
64.37M
52.42M
Operating expense
51.57M
56.18M
66.90M
52.88M
Total operating expenses
190.30M
187.93M
195.53M
203.46M
Operating income
31.48M
34.56M
29.15M
44.42M
Other non operating income
-
-
-590.00K
-
EBT including unusual items
26.58M
29.68M
24.91M
40.41M
EBT excluding unusual items
26.58M
29.68M
24.90M
40.41M
Income tax expense
6.38M
7.11M
5.86M
9.69M
Effective tax rate
24.00%
23.96%
23.52%
23.99%
Other operating expenses
154.00K
76.00K
2.00M
468.00K
Net income
20.20M
22.57M
19.05M
30.71M
Net profit margin
9.11%
10.14%
8.48%
12.39%
Earnings per share
-
-
-
-
Interest and investment income
1.42M
1.53M
1.52M
1.58M
Interest expense
-6.32M
-6.40M
-5.19M
-5.60M
Net interest expenses
-4.90M
-4.88M
-3.67M
-4.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
42.88M
45.74M
32.61M
55.43M
Gain or loss from assets sale
-10.00K
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer